Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | TP53BP1 | Q12888 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4412454 | 0.98 | APP (0.39) | APPPOLBEPHX2HRH4HRH3 | |
| SCHEMBL353687 | 0.95 | APP (0.41) | APPPOLBEPHX2HRH4HRH3 | |
| SCHEMBL22800827 | 0.93 | EPHX2 (0.41) | APPPOLBEPHX2HRH4HRH3 | |
| SCHEMBL918752 | 0.86 | LMNA (0.36) | APPPOLBEPHX2LMNABLM | |
| SCHEMBL4972929 | 0.84 | APP (0.39) | APPEPHX2LMNABLMPTGS1 | |
| SCHEMBL4404059 | 0.84 | LMNA (0.35) | APPPOLBLMNABLMPTGS1 | |
| SCHEMBL12248067 | 0.81 | APP (0.37) | APPEPHX2LMNABLMPTGS1 | |
| SCHEMBL21787654 | 0.81 | APP (0.37) | APPEPHX2LMNABLMPTGS1 | |
| SCHEMBL11245300 | 0.81 | APP (0.37) | APPEPHX2LMNABLMPTGS1 | |
| SCHEMBL918261 | 0.81 | EPHX1 (0.37) | APPEPHX2LMNABLMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150291874-A1 | METHODS FOR MAKING AND USING NOVEL FOAMER COMPOSITIONS | WEATHERFORD TECHNOLOGY HOLDINGS, LLC | 2015-10-15 | — | — | US | claimed |
| US-9018145-B2 | Foamer composition and methods for making and using same | Lubrizol Oilfield Solutions, Inc. (US) | 2015-04-28 | — | — | US | claimed |
| US-8714283-B2 | Foamer/sulfur scavenger composition and methods for making and using same | CLEARWATER INTERNATIONAL, LLC (US) | 2014-05-06 | — | — | US | claimed |
| US-20120088697-A1 | FOAMER/SULFUR SCAVENGER COMPOSITION AND METHODS FOR MAKING AND USING SAME | WEATHERFORD/LAMB, INC. | 2012-04-12 | — | — | US | claimed |
| US-7906109-B2 | Pharmaceutical composition comprising an active principal and sulphobetaine | LEK PHARMACEUTICALS D.D. (SL) | 2011-03-15 | — | — | US | claimed |
| CN-100528840-C | Improved drug candidates and methods for their preparation | NEUROCHEM INTERNAT LTD (CH) | 2009-08-19 | — | — | CN | claimed |
| EP-1729794-B1 | A PHARMACEUTICAL COMPOSITION COMPRISING A NON-DETERGENT SULPHOBETAINE | LEK PHARMACEUTICALS (SI) | 2008-07-09 | — | — | EP | claimed |
| US-20080027097-A1 | PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2008-01-31 | — | — | US | claimed |
| US-20070184019-A1 | Pharmaceutical composition comprising an active principal and sulphobetaine | LEK PHARMACEUTICALS D.D. (SI) | 2007-08-09 | — | — | US | claimed |
| US-7253306-B2 | Pharmaceutical drug candidates and methods for preparation thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-08-07 | — | — | US | claimed |
| WO-2005007895-A1 | METHODS AND KITS FOR OBTAINING NUCLEIC ACID FROM BIOLOGICAL SAMPLES | APPLERA CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| US-20050009036-A1 | Methods and kits for obtaining nucleic acid from biological samples | APPLERA CORPORATION (US) | 2005-01-13 | — | — | US | claimed |
| WO-2004113391-A2 | IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2004-12-29 | — | — | WO | claimed |
| EP-0972333-B1 | METHODS AND SYSTEMS FOR ENHANCED FLUID TRANSPORT | CALIPER LIFE SCIENCES INC (US) | 2004-11-24 | — | — | EP | claimed |
| US-6129826-A | APPARATUS FOR ENHANCING TRANSPORT AND DIRECTION OF MATERIALS IN FLUIDIC SYSTEMS UTILIZING ELECTROOSMOTIC FLOW SYSTEMS, BY ADDING ZWITTERIONIC COMPOUND(S) TO THE FLUID CONTAINING THE MATERIAL TO BE TRANSPORTED OR DIRECTED | CALIPER TECHNOLOGIES CORP. (US) | 2000-10-10 | — | — | US | claimed |
| EP-0972333-A4 | METHODS AND SYSTEMS FOR ENHANCED FLUID TRANSPORT | CALIPER TECHN CORP (US) | 2000-06-28 | — | — | EP | claimed |
| EP-0972333-A1 | METHODS AND SYSTEMS FOR ENHANCED FLUID TRANSPORT | Caliper Technologies Corporation (US) | 2000-01-19 | — | — | EP | claimed |
| US-5964995-A | ENHANCING MATERIAL DIRECTION AND TRANSPORT BY ELECTROOSMOTIC FLOW OF A FLUID CONTAINING THAT MATERIAL BY ADDING A ZWITTERIONIC COMPOUND; REDUCING ELECTROPHORETIC SEPARATION OF DIFFERENTIALLY CHARGED SPECIES IN A MICROSCALE FLUID COLUMN | CALIPER TECHNOLOGIES CORP. (US) | 1999-10-12 | — | — | US | claimed |
| WO-1998045929-A9 | METHODS AND SYSTEMS FOR ENHANCED FLUID TRANSPORT | — | 1999-03-11 | — | — | WO | claimed |
| WO-1998045929-A1 | METHODS AND SYSTEMS FOR ENHANCED FLUID TRANSPORT | CALIPER TECHNOLOGIES CORPORATION (US) | 1998-10-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070184019-A1 | Pharmaceutical composition comprising an active principal and sulphobetaine | SCN2B, SCN1B, SPTSSB | APP 2443/4885POLB 367/4885EPHX2 2748/4885 |
| US-20080027097-A1 | PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | MPST, TTR, STS | APP 86/4885POLB 3707/4885EPHX2 2293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.